Is Clearmind Medicine Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Clearmind Medicine Inc (CMND) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Clearmind Medicine Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Clearmind Medicine Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Clearmind Medicine Inc?

Muslim investors may consider investing in Clearmind Medicine Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Clearmind Medicine Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Clearmind Medicine Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Clearmind Medicine Inc updated?

The Shariah compliance status of Clearmind Medicine Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Clearmind Medicine Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Clearmind Medicine Inc?

You can check the latest Shariah compliance status of Clearmind Medicine Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CMND Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 05, 2026

Report Source: 2025 Annual Report

Clearmind Medicine Inc. Stock Analysis CMND

United States Health Care Nano Cap Report: 2025 Annual

Clearmind Medicine, Inc. is a psychedelic pharmaceutical biotech company. The firm is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The firm researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Company’s intellectual portfolio consists of 19 patent families including 31 granted patents.

Key Statistics of Clearmind Medicine Inc (CMND)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.52$0.54

Today's Open

$0.52

Volume

264.96K

P/E Ratio (TTM)

52 Week Range

$0.52$52.40

Market Cap

1.28M

Avg. Volume

11.70M

Dividend Yield

Financial Metrics & Statements of Clearmind Medicine Inc (CMND)

FAQ's for Clearmind Medicine Inc (CMND)

According to Musaffa’s Shariah screening methodology, Clearmind Medicine Inc (CMND) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.